Related Experiment Video
Updated: Feb 20, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and
Subhasheenee Ganesan1, Lea Mansour2, Amanda Dibden2
1Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom; Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, United Kingdom.
Objective:
NBN is a putative ovarian cancer susceptibility gene. The association between a pathogenic variant in NBN and ovarian cancer is not well established. We aimed to estimate the ovarian cancer risk in unselected women with an NBN pathogenic variant.
Data Sources:
PubMed and Embase searched from inception to January 2026.
Eligibility Criteria:
Population: Women diagnosed with ovarian cancer undergoing germline sequencing of NBN (intervention).
Study Appraisal And Synthesis Methods:
We followed a prospective protocol as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (International Prospective Register of Systematic Reviews [PROSPERO]: CRD42024567791). The number of NBN pathogenic variants in ovarian cancer cases in included studies was pooled and an estimated odds calculated. This was compared to the odds of an NBN loss-of-function variant in Genome Aggregation Database v4.1 controls of matched ethnicities to obtain the odds ratio of ovarian cancer with an NBN pathogenic variant. We performed prespecified subgroup analyses for high-grade serous carcinoma and non-high-grade serous carcinoma, and those with a family history of ovarian cancer.
Results:
Searches yielded 9025 studies; 57 studies (n=40,537) were included in our initial analysis: 36 in majority White cohorts (n=33,822) and 21 in non-White cohorts (n=6715). In the White cohorts, the odds ratio of ovarian cancer with an NBN pathogenic variant was 1.68 (95% confidence interval, 1.37-2.07; P<.001), and the derived relative risk and lifetime risk of ovarian cancer 1.66% and 3.32%, respectively. For the most common pathogenic variant c.657_661del, the odds ratio was 2.69 (95% confidence interval, 1.58-4.57; P<.001), and the relative risk and lifetime risk of ovarian cancer 2.60% and 5.2%, respectively. The odds ratio of high-grade serous carcinoma and non-high-grade serous carcinoma is 1.58 (95% confidence interval, 1.02-2.45; P=.039) and 2.43 (95% confidence interval, 1.56-3.81; P<.001), respectively. Data in non-White cohorts and in ovarian cancer cases with family history were insufficient for any meaningful inference.
Conclusion:
There is a clear association between an NBN pathogenic variant and ovarian cancer in the White population, and this may be stronger with non-high-grade serous carcinoma compared to high-grade serous carcinoma. Further data are required to confirm the association with family history or establish any association in the non-White population. NBN pathogenic variants could be combined with other nongenetic and genetic (polygenic risk score) ovarian cancer risk factors using complex ovarian cancer risk-prediction models going forward, to identify several NBN-positive women at an ovarian cancer risk level for offering surgical prevention.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Single Nucleotide Polymorphisms-SNPs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Oogenesis

